Hologic’s HOLX progress in the domestic and international markets, a strong pipeline of products and continued solid performance of the Molecular Diagnostics segment bolster our confidence. The stock ...
The latest update on Hologic centers on a very slight trim to the fair value estimate, from about US$76.50 to about US$76.42 per share. This keeps it closely aligned with the proposed acquisition ...
Thought LeadersSarah Smith and Tim SimpsonSenior Marketing Manager and General ManagerHologic In celebration of International Women's Day 2024, we're honored to host Tim Simpson and Sarah Smith from ...
Women’s health medical device maker, Hologic HOLX, is struggling with continued softness in its core Breast Health segment. Sales fell 6.2% in the fiscal 2025 second quarter due to weaker sales of ...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Hologic is back in focus as analysts update their price ...
On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions ...
Forbes contributors publish independent expert analyses and insights. Jenn Nelson covers women’s sports business and athlete features. The WTA has a proud legacy of prioritizing athlete health, rooted ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today preliminary revenue results for its first fiscal quarter ended December 28, 2024. The Company expects to report total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results